PMN
PMN
NASDAQ · Biotechnology

Promis Neurosciences Inc

$13.49
+0.79 (+6.22%)
As of Apr 1, 3:56 PM ET ·
Financial Highlights (FY 2025)
Revenue
3.59M
Net Income
732.2K
Gross Margin
56.5%
Profit Margin
20.4%
Rev Growth
+3.4%
D/E Ratio
0.28
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 56.5% 56.5% 56.5%
Operating Margin 20.4% 24.1% 24.6%
Profit Margin 20.4% 16.5% 17.3%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 3.59M 3.48M 3.01M
Gross Profit 2.03M 1.97M 1.70M
Operating Income 731.5K 837.8K 740.9K
Net Income 732.2K 573.7K 520.4K
Gross Margin 56.5% 56.5% 56.5%
Operating Margin 20.4% 24.1% 24.6%
Profit Margin 20.4% 16.5% 17.3%
Rev Growth +3.4% -1.6% +9.6%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 5.02M 4.83M 4.48M
Total Equity 17.93M 18.85M 18.29M
D/E Ratio 0.28 0.26 0.25
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 1.09M 1.00M 849.7K
Free Cash Flow 537.7K 589.4K 453.2K